Tenofovir Disoproxil Fumarate(Tdf) Tablets

Form: Oral tablets

Strength: 300 mg

Reference Brands: Viread® (EU & US)

Category: Hepatitis

Tenofovir Disoproxil Fumarate (TDF) is a potent nucleotide reverse transcriptase inhibitor used to treat chronic Hepatitis B virus (HBV) infection and HIV-1. Available as oral tablets at 300 mg strength, TDF effectively blocks viral replication by inhibiting viral reverse transcriptase enzymes, reducing viral load and preventing disease progression. Marketed under the brand name Viread® by Gilead Sciences, it is approved by the US FDA and EMA. Widely prescribed in both the EU and US, Tenofovir Disoproxil Fumarate is essential for pharma B2B suppliers and healthcare providers managing viral hepatitis and HIV therapies.